SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-041796
Filing Date
2019-11-07
Accepted
2019-11-07 16:26:44
Documents
13
Period of Report
2019-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asmb-8k_20191107.htm   iXBRL 8-K 35119
2 EX-99.1 asmb-ex991_24.htm EX-99.1 365563
  Complete submission text file 0001564590-19-041796.txt   546034

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA asmb-20191107.xsd EX-101.SCH 5980
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE asmb-20191107_lab.xml EX-101.LAB 19493
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asmb-20191107_pre.xml EX-101.PRE 11639
9 EXTRACTED XBRL INSTANCE DOCUMENT asmb-8k_20191107_htm.xml XML 3554
Mailing Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032
Business Address 11711 N. MERIDIAN STREET SUITE 310 CARMEL IN 46032 (212) 554-4388
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35005 | Film No.: 191200754
SIC: 2834 Pharmaceutical Preparations